甲状腺功能亢进药物和物理治疗机制研究(4)
[14] Miyauchi S,Matsuura B,Onji M.Increased Levels of Serum lnterleukin-18 in Graves' Disease[J].Thyroid,2000,10(9):815-819.[15] 李学军,闫冰,赵岩.甲巯咪唑对 Graves 病患者外周血清 Th1 和 Th2 细胞因子的影响[J].福建医科大学学报,2008,42(6):533-535.
[16] Aniszewski JP,Valyasevi RW,Bahn RS.Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy[J].The Journal of Clinical Endocrinology & Metabolism ......
您现在查看是摘要页,全文长 2749 字符。